NuggMD Launches in UK, Integrates Stripe for Seamless Cannabis Payments

NuggMD, a leading telehealth platform for cannabis, has expanded its services to the United Kingdom and integrated with Stripe to streamline payments for medical cannabis patients. This move aims to reduce friction at the point of sale, allowing patients to pay for prescriptions more easily. The integration leverages Stripe's programmable financial services to enhance speed, security, and cost-effectiveness. According to a poll by The Cannabis Consumer Poll, 79% of cannabis consumers expect dispensaries to accept debit card payments, highlighting the demand for digital payment options in the sector.

NuggMD CEO Charlie Russell expressed enthusiasm about the UK launch and collaboration with Stripe, noting that the partnership brings speed, confidence, and savings to the UK's approximately 75,000 active patients and nearly 700,000 annual prescriptions processed online. NuggMD connects patients with licensed medical cannabis practitioners in the US, UK, and Germany, and has facilitated over 2 million evaluations since 2015. The company also operates The Cannabis Consumer Poll, which surveys a representative sample of cannabis consumers in the $47 billion state-legal US market.

This expansion underscores NuggMD's commitment to international growth and improving patient access through technology. By integrating Stripe, NuggMD addresses a critical pain point for medical cannabis patients in the UK, ensuring they can pay for their prescriptions as conveniently as for any other product or service. The move also positions NuggMD to capture a growing market, as the UK continues to expand its medical cannabis program.